EQS-News

BioLizard Appoints Matthew Hall as Director of Business Development

EQS-News: BioLizard nv / Key word(s): Personnel BioLizard Appoints Matthew Hall as Director of Business Development 18.04.2024 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. BioLizard Appoints Matthew Hall as Director of Business Development

• Matthew G. Hall, PhD, brings over a decade of experience in strategic partnerships and BD within the biotech and pharmaceutical sectors, with a particular focus on leveraging AI-driven solutions.
• Appointment strengthens BioLizards’ position in the strategically important Swiss market, where the company recently established a new office.
• BioLizard is the trusted go-to partner for data strategy and execution with companies across the range from drug discovery to clinical research and diagnostics. The company has a uniquely qualified team, combining expertise in biology and computer sciences.

Lausanne (Switzerland) and Ghent (Belgium), April 18, 2024 – BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the appointment of Matthew Hall, PhD, as Director of Business Development. Matthew's regional insights, gained from more than a decade as an insider in the Swiss biotech sector, combined with his expertise in AI and biology, make him a perfect fit for the BioLizard team. His unique profile and global network will further empower the company to expand and strengthen its presence in Switzerland and other key markets.

Liesbeth Ceelen, PhD, CEO of BioLizard, said: “We are delighted to welcome Matthew Hall to our team of ‘Lizards’ – as we like to call our employees – as Director of Business Development. His proven track record in biotech and strategic business development aligns perfectly with BioLizard’s mission to drive digital transformation across the life sciences sector. Deeply rooted in the Lausanne area and with an established regional and global network, he will be vital for our company as we build out our foothold at Biopôle, one of the largest biotech hubs in Switzerland and exciting pool for talent. With Matthew on board, we are very confident in our ability to further expand our presence in this crucial market and beyond.”